Integrating Multi-Omics Approaches to Identify Relevant Biomarkers for Fibrosis Clinical Trials

Time: 9:30 am
day: Day One


  • Discussing the translatability of combining biomarkers across disease states and indications
  • Detecting peripheral biomarkers using transcriptomics and proteomics
  • Considering how this applies across indications and how to harness this knowledge
  • Illuminating novel biomarkers to capture the translatability bridge into humans